Silencing α-synuclein gene expression enhances tyrosine hydroxylase activity in MN9D cells

被引:49
作者
Liu, Dongmei [1 ]
Jin, Ling [1 ]
Wang, Hao [1 ]
Zhao, Huanying [1 ]
Zhao, Chunli [1 ]
Duan, Chunli [1 ]
Lu, Lingling [1 ]
Wu, Bo [1 ]
Yu, Shun [2 ]
Chan, Piu [2 ]
Li, Yaohua [2 ]
Yang, Hui [1 ]
机构
[1] Capital Med Univ, Beijing Ctr Neural Regenerat & Repair, Key Lab Neurodegenerat Dis, Beijing Inst Neurosci,Minist Educ, Beijing 100069, Peoples R China
[2] Capital Med Univ, Xuanwu Hosp, Beijing Inst Geriatr, Sino Japan Joint Lab Neurodegenerat Dis, Beijing 100053, Peoples R China
基金
中国国家自然科学基金;
关键词
alpha-synuclein; RNA interference; dopamine; Parkinson's disease;
D O I
10.1007/s11064-008-9599-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
alpha-Synuclein has been implicated in the pathogenesis of Parkinson's disease (PD). Previous studies have shown that alpha-synuclein is involved in the regulation of dopamine (DA) metabolism, possibly by down-regulating the expression of tyrosine hydroxylase (TH), the rate-limiting enzyme in DA biosynthesis. In this study, we constructed alpha-synuclein stably silenced MN9D/alpha-SYN(-) cells by vector mediated RNA interference and examined its effects on DA metabolism. We found that there were no significant differences in TH protein and mRNA levels between MN9D, MN9D/alpha-SYN(-) and MN9D/CON cells, suggesting that silencing alpha-synuclein expression does not affect TH gene expression. However, significant increases in phosphorylated TH, cytosolic 3, 4-dihydroxyphenylalanine (L-DOPA) and DA levels were observed in MN9D/alpha-SYN(-) stop cells. Our data show that TH activity and DA biosynthesis were enhanced by down-regulation of alpha-synuclein, suggesting that alpha-synuclein may act as a negative regulator of cytosolic DA. With respect to PD pathology, a loss of functional alpha-synuclein may result in increased DA levels in neurons that may lead to cell injury or even death.
引用
收藏
页码:1401 / 1409
页数:9
相关论文
共 43 条
[31]   α-synuclein and Parkinson's Disease [J].
Recchia, A ;
Debetto, P ;
Negro, A ;
Guidolin, D ;
Skaper, SD ;
Giusti, P .
FASEB JOURNAL, 2004, 18 (06) :617-626
[32]   Interactions among α-synuclein, dopamine, and biomembranes -: Some clues for understanding neurodegeneration in Parkinson's disease [J].
Rochet, JC ;
Outeiro, TF ;
Conway, KA ;
Ding, TT ;
Volles, MJ ;
Lashuel, HA ;
Bieganski, RM ;
Lindquist, SL ;
Lansbury, PT .
JOURNAL OF MOLECULAR NEUROSCIENCE, 2004, 23 (1-2) :23-33
[33]   Does α-synuclein modulate dopaminergic synaptic content and tone at the synapse? [J].
Sidhu, A ;
Wersinger, C ;
Vernier, P .
FASEB JOURNAL, 2004, 18 (06) :637-647
[34]   α-Synuclein regulation of the dopaminergic transporter:: a possible role in the pathogenesis of Parkinson's disease [J].
Sidhu, A ;
Wersinger, C ;
Vernier, P .
FEBS LETTERS, 2004, 565 (1-3) :1-5
[35]   alpha-synuclein in Lewy bodies [J].
Spillantini, MG ;
Schmidt, ML ;
Lee, VMY ;
Trojanowski, JQ ;
Jakes, R ;
Goedert, M .
NATURE, 1997, 388 (6645) :839-840
[36]  
Stokes AH, 1999, J NEUROSCI RES, V55, P659, DOI 10.1002/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO
[37]  
2-C
[38]   Formation of hydrogen peroxide and hydroxyl radicals from Aβ and α-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease [J].
Tabner, BJ ;
Turnbull, S ;
El-Agnaf, OMA ;
Allsop, D .
FREE RADICAL BIOLOGY AND MEDICINE, 2002, 32 (11) :1076-1083
[39]   Attenuation of dopamine transporter activity by α-synuclein [J].
Wersinger, C ;
Sidhu, A .
NEUROSCIENCE LETTERS, 2003, 340 (03) :189-192
[40]   Differential cytotoxicity of dopamine and H2O2 in a human neuroblastoma divided cell line transfected with α-synuclein and its familial Parkinson's disease-linked mutants [J].
Wersinger, C ;
Sidhu, A .
NEUROSCIENCE LETTERS, 2003, 342 (1-2) :124-128